Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 4,876 shares at $161.54 ($776K) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Scheduled sale ($776k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.27 | 599 | $94K | 12.1% |
| 2 | $157.27 | 599 | $94K | 12.1% |
| 3 | $158.09 | 921 | $146K | 18.8% |
| 4 | $158.09 | 921 | $146K | 18.8% |
| 5 | $159.02 | 132 | $21K | 2.7% |
| 6 | $160.67 | 396 |
| $64K |
| 8.2% |
| 7 | $160.67 | 396 | $64K | 8.2% |
| 8 | $161.54 | 700 | $113K | 14.6% |
| 9 | $163.09 | 80 | $13K | 1.7% |
| 10 | $164.68 | 32 | $5K | 0.7% |
| 11 | $165.87 | 100 | $17K | 2.1% |
| Total | $159.11 avg | 4,876 | $776K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |